Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.
Source: xStation
تتعاون IBM وGroq لإحداث ثورة في معالجة الذكاء الاصطناعي
معاينة صناعة الدفاع الأميركية - هل وصلت إلى ذروتها؟
Waymo: سباق ضد الجهات التنظيمية
هل سيحدث Aegaeon من علي بابا ثورة في استخدام وحدة معالجة الرسومات؟
